Lista de obras - Paul Brennan - Dominio Público Uruguay

A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine

artículo científico

Analysis of human tumour necrosis factor receptor 1 dominant-negative mutants reveals a major region controlling cell surface expression

artículo científico publicado en 2004

Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cells

artículo científico publicado en 2013

Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription

artículo científico publicado en 2001

Defining the prognosis of early stage chronic lymphocytic leukaemia patients

artículo científico publicado en 2011

Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia

artículo científico publicado en 2014

Epstein-Barr virus induces a distinct form of DNA-bound STAT1 compared with that found in interferon-stimulated B lymphocytes

artículo científico publicado en 2007

Epstein-Barr virus regulates STAT1 through latent membrane protein 1.

artículo científico publicado en 2003

Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A

artículo científico publicado en 2006

Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38.

artículo científico publicado en 2010

Key Molecular Drivers of Chronic Lymphocytic Leukemia

artículo científico publicado en 2016

Mimicking the tumour microenvironment: three different co‐culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells ⬇️

artículo científico publicado el 19 de junio de 2012

NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia

artículo científico publicado en 2009

Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells

artículo científico publicado en 2002

Proteomic profiling of human respiratory epithelia by iTRAQ reveals biomarkers of exposure and harm by tobacco smoke components

artículo científico publicado en 2011

Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia

artículo científico publicado en 2014

STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells

artículo científico publicado en 2009

Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie-adenovirus receptor and alphavbeta5 integrin expression

artículo científico publicado en 2005

The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target

artículo científico publicado en 2008

The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine

artículo científico publicado en 2008

Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2.

artículo científico publicado en 2011

Lista de obras de Paul Brennan

A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine

Analysis of human tumour necrosis factor receptor 1 dominant-negative mutants reveals a major region controlling cell surface expression

Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cells

Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription

Defining the prognosis of early stage chronic lymphocytic leukaemia patients

Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia

Epstein-Barr virus induces a distinct form of DNA-bound STAT1 compared with that found in interferon-stimulated B lymphocytes

Epstein-Barr virus regulates STAT1 through latent membrane protein 1.

Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A

Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38.

Key Molecular Drivers of Chronic Lymphocytic Leukemia

Mimicking the tumour microenvironment: three different co‐culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells ⬇️

NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia

Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells

Proteomic profiling of human respiratory epithelia by iTRAQ reveals biomarkers of exposure and harm by tobacco smoke components

Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia

STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells

Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie-adenovirus receptor and alphavbeta5 integrin expression

The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target

The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine

Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2.